Abstract
The chemokine receptor CCR5 is one of the co-receptor of HIV-1 infection. People with homozygous CCR5Δ32 deletion resist HIV-1 infection, which makes the CCR5 an important target for HIV-1 gene therapy. Although the CRISPR/Cas9 has ever been used for HIV-1 study, the newly developed CRISPR/AsCpf1 has never been utilized in HIV-1 co-receptor disruption. The CRISPR/Cpf1 system shows many advantages over CRISPR/Cas9, such as lower off-target, small size of nuclease, easy sgRNA design for multiplex gene editing, etc. Therefore, the CRISPR/Cpf1 mediated gene editing will confer a more specific and safe strategy in HIV-1 co-receptor disruption. Here, we demonstrated that CRISPR/AsCpf1 could ablate the main co-receptor of HIV-1 infection-CCR5 efficiently with two screened sgRNAs via different delivery strategies (lentivirus, adenovirus). The edited cells resisted R5-tropic HIV-1 infection but not X4-tropic HIV-1 infection compared with the control group in different cell types of HIV-1 study (TZM.bl, SupT1-R5, Primary CD4+T cells). Meanwhile, the edited cells exhibited selective advantage over unedited cells while under the pressure of R5-tropic HIV-1. Furthermore, we clarified that the predicted off-target sites of selected sgRNAs we...Continue Reading
References
Jun 20, 1996·Nature·H DengN R Landau
Aug 22, 1996·Nature·M SamsonM Parmentier
Aug 9, 1996·Cell·R LiuN R Landau
Sep 27, 1996·Science·M DeanS J O'Brien
Jun 18, 1998·Cell·D C Chan, P S Kim
Jul 1, 2008·Nature Biotechnology·Elena E PerezCarl H June
Feb 14, 2009·The New England Journal of Medicine·Gero HütterEckhard Thiel
Mar 7, 2009·Science·Douglas D RichmanRoger J Pomerantz
Jul 6, 2010·Nature Biotechnology·Nathalia HoltPaula M Cannon
Dec 15, 2010·Blood·Kristina AllersThomas Schneider
Aug 5, 2011·Nucleic Acids Research·Claudio MussolinoToni Cathomen
Aug 8, 2012·Trends in Immunology·Christine M DurandRobert F Siliciano
Jan 5, 2013·Science·Prashant MaliGeorge M Church
Oct 29, 2013·Nature Reviews. Microbiology·Françoise Barré-SinoussiJean-François Delfraissy
Oct 29, 2013·Blood·Chuka A DidiguRobert W Doms
Mar 7, 2014·The New England Journal of Medicine·Pablo TebasCarl H June
Jun 7, 2014·Cell·Patrick D HsuFeng Zhang
Dec 18, 2014·Cell Stem Cell·Pankaj K MandalChad A Cowan
Apr 10, 2015·The Journal of General Virology·Chang LiQinxue Hu
Oct 21, 2015·Scientific Reports·Panpan HouDeyin Guo
Dec 17, 2015·Molecular Therapy. Nucleic Acids·HyunJun KangIgor I Slukvin
Jun 9, 2016·Nature Biotechnology·Daesik KimJin-Soo Kim
Jun 28, 2016·Nature Biotechnology·Benjamin P KleinstiverJ Keith Joung
Dec 6, 2016·Nature Biotechnology·Bernd ZetscheFeng Zhang
Mar 21, 2017·Molecular Plant·Mugui WangJian-Kang Zhu
Jun 11, 2017·Human Gene Therapy·Songlin YuXiaoping Chen
Sep 15, 2017·Cell & Bioscience·Zhepeng LiuDeyin Guo
Oct 5, 2017·Nucleic Acids Research·Mengjun TuFeng Gu
Nov 17, 2017·Retrovirology·Qiankun WangDeyin Guo
Jan 4, 2019·Retrovirology·Shuhai HeZiqiang Cheng
Feb 26, 2019·Nature Methods·Xiaoyun DaiSidi Chen
Mar 6, 2019·Nature·Ravindra K GuptaEduardo Olavarria
Jun 13, 2019·Retrovirology·Qiaoqiao XiaoDeyin Guo
Sep 12, 2019·The New England Journal of Medicine·Lei XuHu Chen